Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Tropical Diseases Targeted for Elimination: Chagas Disease, Lymphatic Filariasis, Onchocerciasis, and Leprosy

In: Disease Control Priorities in Developing Countries. 2nd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2006. Chapter 22.
Free Books & Documents
Review

Tropical Diseases Targeted for Elimination: Chagas Disease, Lymphatic Filariasis, Onchocerciasis, and Leprosy

Jan H. F. Remme et al.
Free Books & Documents

Excerpt

Tropical diseases are infectious diseases that are found predominantly in the tropics, where ecological and socioeconomic conditions facilitate their propagation. Climatic, social, and economic factors create environmental conditions that facilitate transmission, and the lack of resources prevents affected populations from obtaining effective prevention and adequate care. Tropical diseases are diseases of the poor, and investments in control and research to develop more effective intervention tools and strategies have been minimal (Gwatkin, Guillot, and Heuveline 1999; Remme and others 2002). For some, however, effective intervention methods have been developed, and successful control has been achieved.

This chapter focuses on four tropical diseases—Chagas disease, lymphatic filariasis (LF), onchocerciasis, and leprosy—for which effective means of control are available. All four diseases are targeted for elimination as a public health problem. Control strategies are being implemented at scale and have already achieved a major reduction in the burden of disease, and the causative agent has even been eliminated in some previously endemic areas. Those successes have not come easily, and much remains to be done to ensure complete and sustained control of the diseases.

PubMed Disclaimer

References

    1. Addiss D., Critchley J., Ejere H., Garner P., Gelband H., Gamble C. Albendazole for Lymphatic Filariasis. Cochrane Database of Systematic Reviews. 2004;(1):CD003753. - PubMed
    1. Akhavan, D. 1998. Análise de custo-efetividade do programa de controle da doença de Chagas no Brasil. Brasília: Pan American Health Organization.
    1. Amazigo U. V., Obono M., Dadzie K. Y., Remme J., Jiya J., Ndyomugyenyi R. et al. Monitoring Community-Directed Treatment Programs for Sustainability: Lessons from the African Programme for Onchocerciasis Control (APOC) Annals of Tropical Medicine and Parasitology. 2002;96(Suppl. 1):S75–92. - PubMed
    1. Basombrio M. A., Schofield C. J., Rojas C. L., del Rey E. C. A Cost-Benefit Analysis of Chagas Disease Control in North-western Argentina. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1998;92(2):137–43. - PubMed
    1. Bekri W., Gebre S., Mengiste A., Saunderson P. R., Zewge S. Delay in Presentation and Start of Treatment in Leprosy Patients: A Case-Control Study of Disabled and Non-Disabled Patients in Three Different Settings in Ethiopia. International Journal of Leprosy and Other Mycobacterial Diseases. 1998;66(1):1–9. - PubMed

LinkOut - more resources